Salute e Benessere

Akari Therapeutics Reports First Half 2023 Financial Results and Highlights

Akari's priority pipeline programs remain on track to begin enrollment in the registrational nomacopan Phase 3 clinical trials in pediatric and adult HSCT-TMA and start PAS-nomacopan clinical trials in geographic atrophy (GA)Granted orphan drug designation from the European Commission for treatment in hematopoietic stem cell transplantation, adding to existing FDA Orphan Drug, Fast Track and Rare Pediatric Disease designationsThe company established a Boston U.S. headquarters office to...

British Heart Foundation Features Breakthrough Heart Attack Prevention…

According to BHF, there are around 7.6 million people in the UK living with heart or circulatory disease, and many more who are, but don't even know it yet, because their condition is hidden or silent. On this year's World Heart Day, the British Heart Foundation launches The Hidden Heart programme to explore hidden heart conditions, innovations in research and new treatments. The programme features Caristo's CaRi-Heart technology, with insights from the technology's scientific inventor as well…

Halifax Agrees to Acquire the Worldwide Home Care Division of Sodexo

The Company provides in-home care services across eight countries. Headquartered in Irvine, California, the Company operates as a franchisor in the U.S. in the non-medical personal care sector with 535 franchised territories and 105 company-owned territories. Internationally, the Company offers personal care in Ireland, the U.K., Norway, Denmark, Sweden, and France. In addition, it offers complex care (skilled nursing, therapies and home hospitalization) in the U.K. and Brazil. The Worldwide…

EviDenS de Beauté Unveils First Counter in China at Hangzhou Intime Department…

Notably, the new counter's design concept mirrors the brand's pursuit of French elegance and sophistication and pays homage to the brand's founder, Charles-Edouard Barthes. The perfect fusion of the brand's signature elegant gold and ink-blue color scheme, along with unique totemic carvings on the ceiling, creates an ambiance reminiscent of a palace of fine craftsmanship. Notably, the new counter's design concept mirrors the brand's pursuit of French elegance and sophistication and pays…

AMBU FINANCIAL CALENDAR FOR 2023/24

This financial calendar lists the expected release dates of Ambu's financial announcements for the financial year 2023/24, as well as the date of Ambu's Annual General Meeting. 20238 NOVEMBER 2023Annual Report 2022/2313 DECEMBER 2023Annual General Meeting 2023 202430 JANUARY 2024Earnings release Q1 2023/2414 MAY 2024Earnings release Q2 2023/2430 AUGUST 2024Earnings release Q3 2023/2430 SEPTEMBER 2024End of fiscal year...

Dry Eye Syndrome Treatment Market to Reach $9.3 Billion, Globally, by 2032 at…

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca, occurs when eyes get dry due to lack of lubrication by tears. Dry eye syndrome is more common in people ages 50 and older. Dry eye syndrome (DES), also known as keratoconjunctivitis sicca, occurs when eyes get dry due to lack of lubrication by tears. Dry eye syndrome is more common in people ages 50 and older. Request Sample of the Report on Dry Eye Syndrome Treatment Market Forecast 2032- Allied Market Research-...

#UseHeart movement rallies for change as heart disease continues to claim most…

Professor Daniel J. Piñeiro, President of WHF said: "The figures are so staggering that in 2013, ischaemic heart disease featured in the Guinness Book of World Records. We want to set a new record, one that improves the health and access to care for every citizen and mobilises everyone to improve cardiovascular health." ProfessorDaniel J. Piñeiro, President of WHF said:"The figures are so staggering that in 2013, ischaemic heart disease featured in the Guinness Book of World…

Annexin announces success in the company's cancer initiative

"The results we have seen are very exciting as it means that our drug candidate ANXV has the potential to be used together with known chemotherapy drugs to develop new cancer drugs in areas where there are currently no effective treatments. In addition, fewer and milder side effects are expected because the ANXV conjugate is expected to be specifically targeted to the cancer," says Anna Frostegård, CSO and CMO of Annexin Pharmaceuticals. "The results we have seen are very exciting…

Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ)

Sobi Sobi Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Providing reliable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 1,800 employees acrossEurope,North America, theMiddle East,AsiaandAustralia. In 2022, revenue amounted toSEK 18.8 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at...

Nevisense detects skin barrier damage from skin models in research

Nevisense and its underlying Electrical Impedance Spectroscopy (EIS) technology were used to assess the effect of commercially available detergents on the skin barrier of mice and human skin samples. The top-line results of the study indicated that: Nevisense and its underlying Electrical Impedance Spectroscopy (EIS) technology were used to assess the effect of commercially available detergents on the skin barrier of mice and human skin samples. The top-line results of the study indicated…

Neuroblastoma Market to Grow at a Substantial Growth Rate During the Forecast…

Key Takeaways from the Neuroblastoma Market Report Key Takeaways from the Neuroblastoma Market Report Discover which therapies are expected to grab the major neuroblastoma market share @Neuroblastoma Market Report Neuroblastoma Overview Neuroblastoma is a tumor that arises in an infant or kid from neuroblasts usually before the age of 5. It usually appears in infancy and can be identified as early as the first month of life. The tumor is most commonly found in the adrenal...

Nyxoah Announces Partnership with ResMed in Germany

Nyxoah Announces Partnership with ResMedin Germany Creates acontinuum of care in the German obstructive sleep apnea marketMont-Saint-Guibert, Belgium –September28 , 2023 , 10:30pm CET / 4:30pmET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today...

NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating…

Data presented at the 2023 Special Meeting on Pancreatic Cancer of the American Association for Cancer Research Preliminary data show local endoscopic injection of NBTXR3 followed by radiotherapy activation remains feasible with a tolerable safety profile in 15 patientsAs of the data cutoff, in 13 patients evaluable for efficacy, the study showed an injected tumor disease control rate of 92.3% (12/13)Preliminary results from the ongoing study showed median overall survival of 21...

Inventiva reports its 2023 first-half financial results and provides a corporate…

Cash and cash equivalents at €31.2 million, short-term deposits at €0.05 million 1, and long-term deposit at €9.3 million 2, as of June 30, 2023, compared to €86.7 million, €1.0 million and €0.7 million as of December 31, 2022, respectivelRevenues amounted to €1.9 million for the first half of 2023In August 2023, Inventiva received a financing of approximately €35.7 million from new and existing investors consisting of €30.6 million from a capital increase and €5.1 million issuance of...

Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS

New Kit expands suite of NGS Library Prep solutions on the BioXp® System Enabling Speed and Efficiency for Whole genome sequencing (WGS) applications with the Automated Molecular Biology Workstation BioXp® NGS Library Prep kit for Whole Genome Sequencing on the BioXp 3250 and BioXp 9600 systems. This NGS library prep kit enables on-demand and automated library preparation of up to 96 genomic DNA samples for use in whole genome sequencing applications. This new automation capability...

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Company Announcement COPENHAGEN, Denmark; September 28, 2023 –Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 7,609 restricted stock units and 7,873 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a right and obligation to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on...

A Framework to Evaluate the Clinical Utility of Multicancer Early Detection…

The Multicancer Early Detection Consortium Clinical Utility Workgroup has released a paper, Evaluating the Clinical Utility of Multi-Cancer Early Detection (MCED) Tests: Envisioning A Path Forward, to inform providers, guideline developers, regulators, payers, and other decision-makers who will need to make judgments about the benefits and risks of MCED testing in the context of substantial uncertainty. TheMulticancer Early Detection Consortium Clinical Utility Workgrouphas released a...

VIRBAC: current operating income before R&D slightly improving throughout first…

CONSOLIDATED FIGURES AS AT JUNE 30 in € million 20232022 restated 5 2023/2022 change Revenue610.5616.4-1.0% Change at constant exchange rates +0.4% Change at constant exchange rates and scope 1 +0.4% Current operating income, before depreciation of assets from acquisitions 2 109.9117.4-6.4% as a % of revenue - before R&D and at constant rates25.0%24.6% as a % of revenue ...

The Veterinary Telehealth Market Is Expected To Grow At A Rate Of More Than 18%…

Rising Pet Ownership Fueling Market Growth Rising Pet Ownership Fueling Market Growth One of the primary factors contributing to the rapid expansion of theveterinary telehealth marketis the surge in pet ownership. Millennials and Generation Z, as reported by the American Pet Products Association, accounted for nearly half of the pet-owning population inthe United Statesin 2022. Additionally,Chinais expected to witness significant growth in its domestic cat and dog populations,...

Metabolism Assays Market worth $2.1 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Browse in-depth TOC on "Metabolism Assays Market"126 - Tables38 - Figures 192 - Pages Metabolism Assays Market Scope: Assay Kits and reagents segment is expected to account for the larger share in 2022. The metabolism assay market, by product, has been segmented...

Aircraft Engine Forging Market is Forecast to Reach US$ 22 Billion in 2028, Says…

Click here for a free sample pdf: https://www.stratviewresearch.com/Request-Sample/3521/aircraft-engine-forging-market.html#form Click here for a free sample pdf: https://www.stratviewresearch.com/Request-Sample/3521/aircraft-engine-forging-market.html#form Report Highlights Segment Insights on Aircraft Engine Forging Market The Aircraft Engine Forging Market is segmented by aircraft type, process type, component size type, material type, engine type, application...

Maybelline New York Makes a Splash in Roblox: A Digital Makeup and Music…

Emily Arkells, Vice President of Digital for Maybelline New York, states, "As the leading makeup brand in the digital space, Maybelline is committed to providing consumers with new and exciting experiences that promote self-expression. Our partnership with Splash on Roblox allows us to seamlessly integrate our products into an interactive world. With a diverse range of virtual makeup looks created by talented makeup and 3D artists, users can now experiment with different styles and…

Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy…

Trial participants with Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type 4J (CMT4J) could benefit from this joint effort to manufacture new gene therapies that utilize adeno-associated virus serotype 9 (AAV9) to deliver corrected genes SPG50 is a rare disease caused by mutations in the adaptor protein complex-4 mu 1 subunit (AP4M1), which is a protein responsible for intracellular vesicle trafficking, specifically the sorting and transport of membrane proteins within cells...

Theriva Biologics to Participate in the Emerging Growth Conference

The Emerging Growth ConferenceFormat: Corporate presentation and one-on-one investor meetings Presentation Date: Thursday, October 5, 2023 Presntation Time: 9:40 AM ET Registration Link: clickhere The webcast of the presentation will also be available through theconference portaland on the Emerging GrowthYouTube Channel. The replay of the presentation will be accessible in the “Investors” section of the company's website,https://www.therivabio.com, under “Events.” About...

Altri Comunicati